In 2000, a gene expression analysis by Perou et al. characterized breast tumour expression profiles that clustered into four distinct groups: luminal-like, normal-breast-like, human epidermal growth factor receptor 2 (HER2) enriched, and basal-like/triple-negative breast cancer (TNBC) [16]. Here, ERBB2 is linked to triple-negative breast carcinoma.